Addivant Antioxidant in Commercial Trials
- Published: November 06, 2015
DANBURY, CT | Addivant reports that global polymer producers have accelerated their commercial production trials of WESTON 705 liquid phosphite antioxidant on the heels of gaining further FDA approvals. The nonylphenol-free liquid phosphite antioxidant product is said to offer superior performance in protecting the polymer during its total plastic life cycle.
“We are very excited with WESTON 705’s progress globally in commercial production trials,” says Peter Smith, president of Commercial Operations. “The market is responding to greater consumer demands for packaging materials that are tested to meet both today’s FDA and global standards and support the trends to healthier foods. Our resin partners are very aware of the attention and investment that we have placed into the toxicological testing and certification of WESTON 705 and are now looking to benefit from an advanced technology that was specifically designed to meet the needs of the polyethylene film industry.” He adds, “We expect to see polyethylene resins with the WESTON 705 inside to be launched in to the market in very near future.”
To expedite commercial production trials, Addivant has engineered WESTON 705 to enable optimal resin processing, allowing for higher extrusion output and reduced down times. Company says the higher performance of WESTON 705 also helps to better protect the polymer against degradation caused by heat and exposure to the atmosphere, improving the optical performance, and reducing the generation of gels in the finished plastic articles’ well-known problems in the packaging industry.
